ImmunAdd Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
ImmunAdd General Information
Description
Developer of pharmaceutical ingredients designed to boost immune responses in vaccines and treatments. The company's technology utilizes a proprietary plant cell culture platform to sustainably manufacture saponin-based adjuvants, enabling pharmaceutical manufacturers to enhance vaccine effectiveness and stability while ensuring a secure supply of critical immunomodulators for improved patient care.
Contact Information
Website
www.immunadd.comCorporate Office
- 11 Floor.-8, Number 130, Sector. 2, Zhongxiao E. Road
- Zhongzheng District
- Taipei
- Taiwan
Corporate Office
- 11 Floor.-8, Number 130, Sector. 2, Zhongxiao E. Road
- Zhongzheng District
- Taipei
- Taiwan
ImmunAdd Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jul-2026 | Completed | Generating Revenue |
ImmunAdd Patents
ImmunAdd Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025228754-A1 | Adjuvant composition, pharmaceutical composition comprising the same, and method for preventing or treating disease caused by viral infection, bacterial infection, protozoal infection or cancer | Pending | 29-Feb-2024 | ||
| US-20250295763-A1 | Adjuvant composition, pharmaceutical composition comprising the same, and method for preventing or treating disease caused by viral infection, bacterial infection, protozoal infection or cancer | Pending | 29-Feb-2024 | ||
| WO-2025180443-A1 | Adjuvant composition, pharmaceutical composition comprising the same, and method for preventing or treating disease caused by viral infection, bacterial infection, protozoal infection or cancer | Pending | 29-Feb-2024 | A61K39/39 |
ImmunAdd Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bailey Biofund | Venture Capital | Minority | ||
| Diamond Biofund | Venture Capital | Minority |
ImmunAdd FAQs
-
When was ImmunAdd founded?
ImmunAdd was founded in 2022.
-
Where is ImmunAdd headquartered?
ImmunAdd is headquartered in Taipei, Taiwan.
-
What industry is ImmunAdd in?
ImmunAdd’s primary industry is Drug Discovery.
-
Is ImmunAdd a private or public company?
ImmunAdd is a Private company.
-
What is ImmunAdd’s current revenue?
The current revenue for ImmunAdd is .
-
Who are ImmunAdd’s investors?
Bailey Biofund and Diamond Biofund have invested in ImmunAdd.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process